Conflict of Interest

Jennifer Doudna Disclosures

The Regents of the University of California have patents issued and pending for CRISPR technologies on which J.A.D. is an inventor.

J.A.D. is a cofounder of Caribou BiosciencesEditas Medicine, Scribe Therapeutics, Intellia Therapeutics and Mammoth Biosciences. J.A.D. is a scientific advisory board member of Caribou BiosciencesIntellia TherapeuticseFFECTOR Therapeutics, Scribe Therapeutics, Mammoth BiosciencesSynthego, Algen Biotechnologies, Felix Biosciences and Inari. J.A.D. is a Director at Johnson & Johnson and has research projects sponsored by BiogenPfizer,  AppleTree Partners and Roche.